Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Share-based Compensation (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Share-based Compensation for 3 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 27.24% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $6.8 million, down 2.28%, while the annual FY2025 figure was $6.8 million, 2.28% down from the prior year.
  • Share-based Compensation hit $1.6 million in Q4 2025 for Artiva Biotherapeutics, down from $1.6 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $2.2 million in Q4 2024 and bottomed at $1.4 million in Q3 2023.
  • Average Share-based Compensation over 3 years is $1.7 million, with a median of $1.6 million recorded in 2025.
  • Year-over-year, Share-based Compensation soared 56.9% in 2024 and then fell 27.24% in 2025.
  • Artiva Biotherapeutics' Share-based Compensation stood at $1.4 million in 2023, then surged by 56.9% to $2.2 million in 2024, then fell by 27.24% to $1.6 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $1.6 million, $1.6 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.